Relmada Therapeutics (RLMD) Interest & Investment Income (2014 - 2026)
Relmada Therapeutics' (RLMD) quarterly Interest & Investment Income came in at $959762.0 in Q1 2026, up 117.99% year-on-year from $440287.0 in Q1 2025, and up 147.85% on a QoQ basis from $387231.0 in Q4 2025.
Relmada Therapeutics (RLMD) Interest & Investment Income (2014 - 2026) Analysis & Trends
Relmada Therapeutics (RLMD) has 8 years of Interest & Investment Income data on file, last reported at $959762.0 in Q1 2026.
- On a quarterly basis, Interest & Investment Income rose 117.99% year-over-year to $959762.0 in Q1 2026; TTM through Mar 2026 was $1.9 million, a 34.28% decrease from a year earlier, with the FY2025 full-year figure at $1.4 million, down 60.45% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $959762.0, up from $387231.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for RLMD reached as high as $1.4 million in Q2 2023 and fell as low as $247013.0 in Q3 2025.
- Historically, Interest & Investment Income has averaged $849036.6 across 4 years, with a median of $959762.0 in 2026.
- Across the five-year window, Interest & Investment Income slumped 71.16% in 2025 and surged 117.99% in 2026, its largest moves.
- Year by year, Interest & Investment Income stood at $1.3 million in 2023, then tumbled by 48.01% to $654642.0 in 2024, then plunged by 40.85% to $387231.0 in 2025, then soared by 147.85% to $959762.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $959762.0 in Q1 2026, $387231.0 in Q4 2025, and $247013.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Relmada Therapeutics | 452.90 Mn | 452.90 Mn | - | 959,762.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 959,762.00 |
| Dec 31, 2025 | 387,231.00 |
| Sep 30, 2025 | 247,013.00 |
| Jun 30, 2025 | 321,458.00 |
| Mar 31, 2025 | 440,287.00 |
| Dec 31, 2024 | 654,642.00 |
| Sep 30, 2024 | 856,478.00 |
| Jun 30, 2024 | 963,013.00 |
| Mar 31, 2024 | 1.06 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 1.32 Mn |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.21 Mn |
| Sep 30, 2020 | 363,300.00 |
| Jun 30, 2020 | 404,004.00 |
| Sep 30, 2019 | 66,965.00 |
| Jun 30, 2019 | 29,049.00 |
| Dec 31, 2015 | 843.00 |
| Sep 30, 2015 | 1,044.00 |
| Jun 30, 2015 | 1,233.00 |